Page 467 - ONLINE PROCEEDING BOOK WSAVA 2017
P. 467

WSVA7-0284
HILL’S: NEPHROLOGY
PROTEINURIA IN DOGS AND CATS
R. Jepson1
1Royal Veterinary College, Clinical Science and Services, London, United Kingdom
PROTEINURIA IN DOGS AND CATS
Rosanne E. Jepson BVSc MVetMed PhD DipACVIM DipECVIM MRCVS
Royal Veterinary College, London (UK)
Renal proteinuria can be identi ed in both dogs and cats. It can be part of a primary renal disease process e.g. primary glomerular or tubular disease or may represent
a manifestation of renal disease in association with another underlying condition. In health the concentration of protein in the urine is typically low with urine protein to creatinine ratios (UPC) typically <0.2 in cats (up to 0.4 in entire male cats) and <0.5 in dogs.(1-3)
For any patient where proteinuria is identi ed it is important to establish the origin of proteinuria, which may be pre-renal, renal or post-renal. Pre-renal proteinuria
is typically the result of increased circulating plasma proteins and is most often identi ed in relation to elevated circulating immunoglobulins, for example Bence Jones Proteinuria in patients with multiple myeloma. Indication for the presence of a pre-renal proteinuria may therefore come from assessment of a biochemical pro le. Mild increase in proteinuria can also be identi ed in certain physiological states such as after extreme exercise or in association with pyrexia. Post-renal proteinuria results from protein originating from the lower urinary tract, for example in association with urinary tract infection or in ammation. In the investigation for any renal cause
of proteinuria, exclusion of both pre- and post-renal proteinuria is necessary.
Renal proteinuria can be either tubular or glomerular in origin although the magnitude of proteinuria is typically more signi cant in patients with glomerular than tubular disease. A number of methods are available for the assessment. An initial assessment is usually made on the basis of dipstick evaluation. This should be interpreted in light of urine speci c gravity (USG) given that 2+ protein is more likely to be of signi cance with a USG of 1.012 than 1.045. However, ultimately if assessment of proteinuria
is required this should be quanti ed with a UPC.(4, 5) Studies have evaluated the day-to-day variability in UPC for assessment of proteinuria and particularly for patients that are more markedly proteinuric (UPC >2) consideration should be given to pooling equivolumes of urine from 3 consecutive days for submission rather than a single spot
urine sample.(6) It is also important to appreciate that this day to day variability means that in order for a signi cant change in UPC to be identi ed for a patient with UPC ~0.5 the change must be in around 80% whilst for more markedly proteinuric patients (UPC ~4) a 50% reduction is required for the change to be deemed signi cant.(7) Free catch samples are suitable for assessment of UPC and samples obtained from a home environment may
be preferable.(8) Haematuria is unlikely to substantially alter the UPC of a urine sample unless there is gross haematuria.(9) Historically there has been interest in assessment of speci c urinary proteins e.g. albuminuria although to date there have not been studies that support superiority of this over assessment of UPC in clinical practice.
In patients with renal tubular disease e.g. tubulointerstitial nephritis, the presence of proteinuria re ects both
altered haemodynamics due to loss of functioning nephrons and altered tubular reabsorption of proteins.
In these conditions, proteins are typically low molecular weight and the overall magnitude of proteinuria is low (UPC<2.0). Nevertheless, even this low magnitude of proteinuria has been associated with the development
of azotaemia, survival and progression of disease in
cats with CKD and outcome in dogs with CKD.(10, 11) Given the potential for proteinuria to play a role in the progression of disease, antiproteinuric therapy forms part of the recommended treatment plan for both dogs and cats with persistent proteinuria (UPC>0.4) with many clinicians also considering institution of antiproteinuric therapy even for those patients with borderline proteinuria (UPC 0.2-0.4). It is important to appreciate that in end stage disease proteinuria may fall due to a reduced number of nephrons and therefore reduction
in proteinuria late in the disease process is not always a positive indication if azotaemia is deteriorating.
In patients with glomerular disease, structural or function change at the glomerulus results in increased  ltration
of proteins that can be low, medium or high molecular weight. Glomerular disease is identi ed more often in dogs than cats. Here the magnitude of proteinuria is typically higher (UPC >2.0) and may be associated with biochemical changes such as hypoalbuminaemia and hypercholesterolaemia which together with the presence of effusions and/or peripheral oedema may be referred to as nephrotic syndrome. Patients with glomerular disease particularly early in the disease cause will not necessarily demonstrate azotaemia as renal function (i.e. GFR) may be normal. Clinical presentation of such patients may therefore range from the clinically asymptomatic (e.g. detected due to hypoalbuminaemia on a routine pre- anaesthetic screen) through to clinical signs referable to renal disease or proteinuria.
An Urban Experience
467


































































































   465   466   467   468   469